HTLV-1 Alters T Cells for Viral Persistence and Transmission.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

1. Epidemiology and Clinical Outcomes of HTLV-1: A Comprehensive Narrative Review of Endemic and Nonendemic Regions.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
   Review
2. APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.International journal of molecular sciences · 2025
   Review
3. Identification of iron metabolism-related key genes and exploration of their potential mechanisms in hemophagocytic lymphohistiocytosis based on transcriptome sequencing.Frontiers in medicine · 2025
   Article
4. How Can We Prevent Mother-to-Child Transmission of HTLV-1?International journal of molecular sciences · 2023
   Review
5. Functional and Pathogenic Roles of Retroviral Antisense Transcripts.Frontiers in immunology · 2022
   Review
6. Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T-cell lymphotropic virus type 1 infection.Frontiers in immunology · 2022
   Article
7. Alternative RNA splicing in cancer: what about adult T-cell leukemia?Frontiers in immunology · 2022
   Review
8. Latency Reversing Agents: Kick and Kill of HTLV-1?International journal of molecular sciences · 2021
   Review
9. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.Cancer science · 2021
   Review
10. Tampering of Viruses and Bacteria with Host DNA Repair: Implications for Cellular Transformation.Cancers · 2021
    Review
11. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.Journal of neurovirology · 2020
    Review
12. HTLV-1 bZIP factor: the key viral gene for pathogenesis.Retrovirology · 2020
    Review
13. Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.Frontiers in microbiology · 2020
    Review
14. HTLV-1 infection of myeloid cells: from transmission to immune alterations.Retrovirology · 2019
    Review
15. NF-κB and MicroRNA Deregulation Mediated by HTLV-1 Tax and HBZ.Pathogens (Basel, Switzerland) · 2019
    Review
16. Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1.Retrovirology · 2019
    Review
17. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 ActivitiesJournal of virology · 2019
    Article
18. HTLV-1 as a Model for Virus and Host Coordinated Immunoediting.Frontiers in immunology · 2019
    Article
19. The Roles of Coinhibitory Receptors in Pathogenesis of Human Retroviral Infections.Frontiers in immunology · 2018
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as